GlassScriptPhysician profile
Chad A Zender
NPI 1619904117
$3,092.36
in general payments reported to CMS, 2019-2025
9 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $352 · 2021: $410 · 2022: $319 · 2023: $169 · 2024: $493 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943 · Travel and Lodging: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.28 |
| Travel and Lodging | $481.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $861.70 | 2019-2024 | |
| Stryker Corporation | $727.52 | 2019-2023 | Vsp System, Vsp Cranial |
| Medical Device Business Services, INC. | $719.23 | 2024-2025 | Matrixcombo |
| Baxter Healthcare | $392.62 | 2022-2024 | |
| Depuy Synthes Sales INC. | $179.76 | 2024-2025 | Trumatch, Matrixmandible, Matrixmidface |
| Isoray, INC | $132.03 | 2019 | |
| Jazz Pharmaceuticals INC. | $33.14 | 2024 | |
| Integra Lifesciences Corporation | $27.62 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polymedics Innovations INC. | $18.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Zender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.